Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Accendra Health (ACH) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to 3.8%.

  • Accendra Health's EBIT Margin fell 7300.0% to 3.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.17%, marking a year-over-year decrease of 39500.0%. This contributed to the annual value of 1.94% for FY2024, which is 29500.0% down from last year.
  • Latest data reveals that Accendra Health reported EBIT Margin of 3.8% as of Q3 2025, which was down 7300.0% from 5.82% recorded in Q2 2025.
  • Accendra Health's EBIT Margin's 5-year high stood at 6.31% during Q1 2021, with a 5-year trough of 5.82% in Q2 2025.
  • For the 5-year period, Accendra Health's EBIT Margin averaged around 1.45%, with its median value being 2.41% (2022).
  • As far as peak fluctuations go, Accendra Health's EBIT Margin soared by 58000bps in 2021, and later plummeted by -83900bps in 2025.
  • Over the past 5 years, Accendra Health's EBIT Margin (Quarter) stood at 2.51% in 2021, then tumbled by -183bps to 2.1% in 2022, then surged by 208bps to 2.26% in 2023, then plummeted by -233bps to 3.01% in 2024, then surged by 226bps to 3.8% in 2025.
  • Its last three reported values are 3.8% in Q3 2025, 5.82% for Q2 2025, and 0.0% during Q1 2025.